期刊
DNA REPAIR
卷 6, 期 11, 页码 1670-1678出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.dnarep.2007.06.002
关键词
interstrand cross-links; mismatch repair; translesion bypass; homologous recombination
资金
- NCI NIH HHS [P01 CA097175-020001, P30 CA016672, P01 CA097175-04, P01 CA097175, CA16672, P01 CA097175-01A20001, R01 CA075160, P01 CA097175-01A25916, P01 CA097175-01A2, CA075160, P01 CA097175-03, CA097175, P01 CA097175-030001, P01 CA097175-02] Funding Source: Medline
DNA interstrand cross-linking agents have been widely used in chemotherapeutic treatment of cancer. The majority of interstrand cross-links (ICLs) in mammalian cells are removed via a complex process that involves the formation of double-strand breaks at replication forks, incision of the ICL, and subsequent error-free repair by homologous recombination. How double-strand breaks effect the removal of ICLs and the downstream homologous recombination process is not clear. Here, we describe a plasmid-based recombination assay in which one copy of the CFP gene is inactivated by a site-specific psoralen ICL and can be repaired by gene conversion with a mutated homologous donor sequence. We found that the homology-dependent recombination (HDR) is inhibited by the ICL. However, when we introduced a double-strand break adjacent to the site of the ICL, the removal of the ICL was enhanced and the substrate was funneled into a HDR repair pathway. This process was not dependent on the nucleotide excision repair pathway, but did require the ERCC1-XPF endonuclease and REV3. In addition, both the Fanconi anemia pathway and the mismatch repair protein MSH2 were required for the recombinational. repair processing of the ICL. These results suggest that the juxtaposition of an ICL and a DSB stimulates repair of ICLs through a process requiring components of mismatch repair, ERCC1-XPF, REV3, Fanconi anemia proteins, and homologous recombination repair factors. (c) 2007 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据